Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

AbbVie Inc. Director's Dealing 2023

Oct 19, 2023

29755_dirs_2023-10-19_147f1271-0810-4fd1-b653-2f0325d75c31.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2023-10-11

Reporting Person: Davis Jennifer L. (N/A)

More from AbbVie Inc.

Regulatory Filings 2026
Jun 1
Regulatory Filings 2026
May 12
Interim / Quarterly Report 2026
May 8
Regulatory Filings 2026
Apr 29
Regulatory Filings 2026
Apr 3
Major Shareholding Notification 2026
Mar 26
Regulatory Filings 2026
Mar 23
Proxy Solicitation & Information Statement 2026
Mar 23
Regulatory Filings 2026
Mar 4
Director's Dealing 2026
Mar 4
View all filings →